Apple is appealing a trade ban that led to the removal of the blood oxygen sensor from its smartwatches. The US Court of Appeals for the Federal Circuit is reviewing the case, with Apple arguing against the ban imposed by the International Trade Commission in 2023. The dispute involves patent infringement claims between Apple and health tech startup Masimo. Apple aims to reintroduce the sensor in future models.
Read more@
